These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
706 related articles for article (PubMed ID: 32723272)
1. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles. Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272 [TBL] [Abstract][Full Text] [Related]
2. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813 [No Abstract] [Full Text] [Related]
3. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles. Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589 [TBL] [Abstract][Full Text] [Related]
4. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity. Li J; Du X; Zheng N; Xu L; Xu J; Li S Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288 [TBL] [Abstract][Full Text] [Related]
5. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene. Shah P; Rajput SJ Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575 [TBL] [Abstract][Full Text] [Related]
6. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
7. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells. Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025 [TBL] [Abstract][Full Text] [Related]
8. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782 [TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103 [TBL] [Abstract][Full Text] [Related]
10. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release. Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295 [TBL] [Abstract][Full Text] [Related]
11. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639 [TBL] [Abstract][Full Text] [Related]
12. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release. Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128 [TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Shenoy D; Little S; Langer R; Amiji M Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488 [TBL] [Abstract][Full Text] [Related]
14. Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery. Hadipour Moghaddam SP; Yazdimamaghani M; Ghandehari H J Control Release; 2018 Jul; 282():62-75. PubMed ID: 29679666 [TBL] [Abstract][Full Text] [Related]
15. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery. Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342 [TBL] [Abstract][Full Text] [Related]
16. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line. Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815 [No Abstract] [Full Text] [Related]
17. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733 [TBL] [Abstract][Full Text] [Related]
19. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery. Zhang Q; Zhao H; Li D; Liu L; Du S Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088 [TBL] [Abstract][Full Text] [Related]
20. Fabricating polydopamine-coated MoSe Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]